Related Experiment Video
Updated: Oct 20, 2025

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles
Jeremy P Bost1, Hanna Barriga2, Margaret N Holme2
1Department of Laboratory Medicine, Karolinska Institutet, Huddinge 14152, Sweden.
Abstract:
Oligonucleotides (ONs) comprise a rapidly growing class of therapeutics. In recent years, the list of FDA-approved ON therapies has rapidly expanded. ONs are small (15-30 bp) nucleotide-based therapeutics which are capable of targeting DNA and RNA as well as other biomolecules. ONs can be subdivided into several classes based on their chemical modifications and on the mechanisms of their target interactions. Historically, the largest hindrance to the widespread usage of ON therapeutics has been their inability to effectively internalize into cells and escape from endosomes to reach their molecular targets in the cytosol or nucleus. While cell uptake has been improved, "endosomal escape" remains a significant problem. There are a range of approaches to overcome this, and in this review, we focus on three: altering the chemical structure of the ONs, formulating synthetic, lipid-based nanoparticles to encapsulate the ONs, or biologically loading the ONs into extracellular vesicles. This review provides a background to the design and mode of action of existing FDA-approved ONs. It presents the most common ON classifications and chemical modifications from a fundamental scientific perspective and provides a roadmap of the cellular uptake pathways by which ONs are trafficked. Finally, this review delves into each of the above-mentioned approaches to ON delivery, highlighting the scientific principles behind each and covering recent advances.
Insights
Oligonucleotides (ONs) are promising therapeutics, but cellular delivery is challenging. This review explores methods like chemical modification, lipid nanoparticles, and extracellular vesicles to improve ON endosomal escape for better therapeutic efficacy.
Area of Science:
- Biotechnology
- Molecular Biology
- Drug Delivery
Background:
- Oligonucleotides (ONs) are a rapidly expanding class of therapeutics targeting DNA and RNA.
- Despite recent FDA approvals, ONs face challenges with cellular internalization and endosomal escape.
- Effective delivery to the cytosol or nucleus is crucial for ON therapeutic action.
Purpose of the Study:
- To review the design and action of FDA-approved ON therapies.
- To classify common ON types and chemical modifications.
- To explore strategies for enhancing ON cellular delivery and endosomal escape.
Main Methods:
- Review of existing literature on oligonucleotide therapeutics and delivery mechanisms.
- Analysis of cellular uptake pathways for ONs.
- Focus on three key delivery strategies: chemical modification, lipid nanoparticles, and extracellular vesicles.
Main Results:
- Discussion of fundamental scientific principles behind various ON classifications and modifications.
- Mapping of cellular trafficking pathways relevant to ONs.
- Highlighting recent advancements in ON delivery approaches.
Conclusions:
- Endosomal escape remains a critical hurdle for oligonucleotide therapeutics.
- Chemical modifications, lipid nanoparticles, and extracellular vesicles show promise for improving ON delivery.
- Further research into these strategies is essential for advancing ON-based therapies.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Biopharmaceutics and Pharmacokinetics: Overview
Bioavailability Enhancement: Drug Permeability Enhancement
Drug Delivery: Enteral Route

